Our research group previously discovered that the peptidyl-prolyl cis/trans-isomerase (PPIase) CYPJ could promote the growth of HCC by preventing G1 phase arrest by activating the cyclin D1 promotor (Chen et al., 2015). The gene discussed is PPIL3; the disease is hepatocellular carcinoma.